Intravenous immunoglobulin and febrile status epilepticus in children with Dravet syndrome: A retrospective multicentre study.
Romane Marc, Nicole Chemaly, Mathieu Kuchenbuch and 7 others
PMID 41225302WHAT IT FOUND
In 14 children with Dravet syndrome, intravenous immunoglobulin was linked to fewer hospitalizations for status epilepticus.
However, this was a small retrospective series without a control group, so the reduction cannot be separated from natural age-related improvement or other treatments.
Key findings
01The median number of emergency hospitalizations for status epilepticus decreased from four during the six months before treatment to one during the six months after treatment.
02Twelve of the fourteen children experienced a reduction in hospitalizations for status epilepticus, while two remained stable and none worsened.
03Adverse events occurred in six of the fourteen children, primarily fever-induced seizures during infusion, and six children required central venous access due to difficulties with standard venipuncture.
STILL TO COME
How it was doneWhat they found
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study included only 14 children and had no control group, making it impossible to determine if the reduction in hospitalizations was due to IVIG or other factors. Febrile status epilepticus naturally becomes less frequent as children with Dravet syndrome age, and most participants were treated in early childhood, so the observed improvement may reflect natural history rather than treatment effect. Changes in antiseizure medications occurred at the same time as IVIG initiation in some cases, making it difficult to isolate the contribution of IVIG. Seasonal variation may have influenced results, as several children started treatment during winter months when viral infections are common, followed by periods of lower viral circulation. The study did not collect data on overall seizure frequency, only hospitalizations for status epilepticus.
The easy way to misread this
Do not conclude that IVIG prevents status epilepticus in Dravet syndrome. The observed reduction in hospitalizations cannot be separated from the natural age-related decline in febrile seizures, concurrent medication changes, or seasonal factors, as there was no control group.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →